News
-
-
-
COMMUNIQUÉ DE PRESSE
BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties -
-
-
COMMUNIQUÉ DE PRESSE
Ordissimo SA: Rapport semestriel 2024 : croissance du CA et diminution de la perte nette
Ordissimo SA annonce une croissance de 17% du chiffre d'affaires et une forte diminution de la perte nette dans son rapport semestriel 2024. Découvrez les détails des résultats financiers et les perspectives pour la fin de l'année -
COMMUNIQUÉ DE PRESSE
IRS Deadline Alert: File Form 941 for Q3, 2024 Today! TaxBandits Offers Reliable E-filing Solutions for Businesses and Tax Professionals
IRS deadline for Form 941 Q3, 2024 is today. TaxBandits e-file provider offers seamless filing solutions. Features include bulk upload, zero reporting, Form 941 Schedule B, and multi e-sign. Flexible payment options and support for Aggregate Filers available